Chris Orlando

Mr. Christopher P. Orlando is the Vice President, General Counsel for the BioPharma Services Division of Thermo Fisher Scientific Inc. He has primary responsibility for all legal matters relating to the businesses within the division globally, including Fisher Clinical Services and Clintrak. Prior to joining Thermo Fisher Scientific, Mr. Orlando was the Senior Vice President, General Counsel and Corporate Secretary of Comprehensive NeuroScience, Inc., a clinical site management organization and CRO with facilities located throughout the United States. He began his legal career in private practice at law firms in New York, focusing on litigation matters including pharmaceutical product liability cases. As a senior in-house counsel with over 20 years of legal experience, Mr. Orlando has drafted, negotiated and closed numerous commercial transactions, including confidentiality agreements, master services agreements, manufacturing and supply contracts, service level agreements, and quality agreements. Drawing on this experience, he led the legal negotiations for the innovative collaboration agreement completed in 2010 between Fisher Clinical Services and Eli Lilly and Company, which resulted in Fisher Clinical Services taking over responsibility for Eli Lilly’s in-house clinical trial materials manufacturing, packaging and labeling operations on-site at the Lilly Technology Center – North in Indianapolis. Mr. Orlando earned a Bachelor of Science degree in Pharmacy from St. John’s University College of Pharmacy and Allied Health in 1989. While practicing as a Registered Pharmacist in hospital and retail settings, he earned his law degree from St. John’s University School of Law in 1993. Mr. Orlando is a member of the bar in New York, New Jersey and Connecticut, and holds an in-house counsel license in the Commonwealth of Pennsylvania. In addition, he is a member of the Association of Corporate Counsel (ACC) and the International Association for Contract & Commercial Management (IACCM).